Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00281528
Status:
TERMINATED
Last Update Posted:
2019-11-22
First Post:
2006-01-24
Brief Title:
Weekly vs Every 2 Week vs Every 3 Week Administration of ABI-007 AbraxaneBevacizumab Combination in Metastatic Breast Cancer
Sponsor:
Organization:
Celgene